Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

ming of the filing of the BLA; the importance of certain secondary endpoints in the CORD I trial, including the difference between the pre- and post-treatment contracture angles and whether patients achieved at least a 50% reduction in their contracture compared to baseline; the utility of XIAFLEX in the treatment of Dupuytren's contracture, including the potential for XIAFLEX as the first-line treatment option for Dupuytren's contracture; the potential of XIAFLEX to revolutionize the treatment for Dupuytren's contracture; the benefits of XIAFLEX compared to surgery for the treatment of Dupuytren's contracture and the ability of XIAFLEX to address the medical need for a non-surgical treatment for Dupuytren's contracture earlier in the disease process; the period of time during which patients receiving XIAFLEX in the studies will be monitored; and products in development for Dupuytren's contracture, Peyronie's disease, Frozen Shoulder syndrome, overactive bladder, pain, hormone replacement and urologic disease. All statements other than statements of historical facts contained in this release, including but not limited to, statements regarding future expectations, plans and prospects for the Company, statements regarding forward-looking financial information and other statements containing the words "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and similar expressions, as they relate to the Company, constitute forward-looking statements. Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2007 under the heading "Risk Factors", which is on
'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and HOUSTON , May 28, 2015 /PRNewswire/ ... today reported financial results for the second quarter and three ... otherwise, are expressed in Canadian dollars and in accordance with ... ESSA recorded a net loss of $5.9 ... March 31, 2015 (Q2-2015), compared to a net loss of ...
(Date:5/28/2015)... ( http://maetrics.com ), a leading international consulting firm focused ... conference, "The cost of non-compliance -- How new regulation is ... Zurich . Hosted by Maetrics ... -based team, experts provided insights on the impact ... exclusive local audience. The event was held in conjunction ...
(Date:5/28/2015)... CENTENNIAL, Colo. , May 28, 2015 /PRNewswire-USNewswire/ ... largest providers of cartilage, cellular, bone, skin and ... wound care to advance patient healing, today announced ... allograft, has been moved to the high-cost reimbursement ... our allografts reach doctors and their patients," said ...
Breaking Medicine Technology:Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... VIEW, Calif., April 11, 2011 VIVUS, Inc. (NASDAQ: ... 56-week CONQUER study were published in ... safety of investigational drug QNEXA in 2,487 patients across 93 ... provided an in-depth look at weight loss and improvements in ...
... Life-saving Colorado start-up UrgentRx today announced the ... credit card-sized packets are available now at Dahl,s pharmacies, ... first made its powdered medications available across Colorado in ... of UrgentRx Aspirin to Go , UrgentRx ...
Cached Medicine Technology:QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 2QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 3QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 4UrgentRx® Launches Innovative Line of Portable Life-Saving Medications Across Iowa 2UrgentRx® Launches Innovative Line of Portable Life-Saving Medications Across Iowa 3
(Date:5/29/2015)... May 29, 2015 Testosterone Centers of Texas ... area, is opening a new center in the Mid-Cities area ... of the Mid Cities. Located on the south side of ... Hurst, the new testosterone center will open in May and ... suffer from low testosterone. , Like TCT’s other testosterone clinics, ...
(Date:5/29/2015)... 29, 2015 The FCPX Colorist brings professional ... editors can adjust curves, hue, saturation and color levels like ... software. , Each FCPX Colorist Tool installs ... the Final Cut Pro X Effects library. This modular set-up ... their footage to achieve endless looks. , FCPX Colorist introduces ...
(Date:5/29/2015)... 29, 2015 AMIA Issues Report on ... of medical data. , Today AMIA released the results ... (EHR). The “ Report of the AMIA EHR ... of EHRs ” was released in the Journal of ... and represents an evolutionary approach in the management ...
(Date:5/29/2015)... Thursday, May 21st was the inaugural Red ... walks of life came together to raise money for kids ... a campaign dedicated to raising money for children and young ... people laugh, the people at Hands-On Seminars decided to host ... they provided food, fun and laughter to their visitors, while ...
(Date:5/29/2015)... Acoustiblok recently resolved a noisy well ... Three Valleys Municipal Water District (Three Valleys MWD) in ... on the project said, “The new Acoustiblok All Weather ... are much better looking than the temporary barriers. We ... us throughout the process, and the customer service was ...
Breaking Medicine News(10 mins):Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Announcing the Release of FCPX Colorist from Pixel Film Studios for Final Cut Pro X. 2Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 2Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 3Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5
... CHICAGO, June 17 Continuing its efforts to educate, inform, ... not-for-profit patient-focused organization, is hosting its 25-minute live call-in show, ... June 22, 2009 at 6:00 PM on Channel 21. ... discussion with Deborah Harper Brown, Clinical Pharmacist, who will inform ...
... Helps Participants Stay on Track and Make Healthy Choices , ... of 1,000 people by the American Heart Association revealed 57 ... regular exercise due to the economy. A healthy lifestyle ... American Heart Association,s Go Red For Women movement and its ...
... BETHESDA, Md. and MINNEAPOLIS, June 17 /PRNewswire-Asia/ -- ... leading independent American,provider of Western healthcare products and services ... (Nasdaq: VTAL ), a leading provider of,advanced ... Vital Images, software as part of the Chindex medical ...
... of the IntelliFlowRx workflow management system provides significant ... ENGLEWOOD, Colo., June 17 Baxa Corporation announces ... management system. IntelliFlowRx is designed to improve ... The system also streamlines compliance with sterile ...
... , , , , Quality Texas ... Award for Performance Excellence , ... Medical Center at Grapevine is the 2009 recipient for the Texas Award for Performance Excellence ... corporation that administers the Texas Award for Performance Excellence. , ...
... induce a state of hibernation that improves recovery, ... -- Hibernation induced by opioid drugs reduced brain ... rats that experienced an experimental stroke, researchers report. ... shown that ,natural hibernation, has anti-ischemic effects," Cesar ...
Cached Medicine News:Health News:The Consumer's Role in Medication Safety -- An Interactive Discussion with a Pharmacist on Live TV 2Health News:Ocean Spray Teams Up With the American Heart Association's Go Red For Women and Its Go Red BetterU Program 2Health News:Ocean Spray Teams Up With the American Heart Association's Go Red For Women and Its Go Red BetterU Program 3Health News:Chindex International and Vital Images Sign Reseller Agreement 2Health News:Chindex International and Vital Images Sign Reseller Agreement 3Health News:Chindex International and Vital Images Sign Reseller Agreement 4Health News:Chindex International and Vital Images Sign Reseller Agreement 5Health News:Baxa Corporation Releases IntelliFlowRx(TM) Upgrades 2Health News:Tarrant County Hospital Takes Top Quality Award in Texas 2Health News:Tarrant County Hospital Takes Top Quality Award in Texas 3
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
... memory capabilities for overnight sleep screening., ,The ... and pulse rate data, and can operate in ... ,1. The Model 130 can retain up ... patient, making the device ideally suited for treadmill ...
Medicine Products: